ACE and heart failure: Despite recent medical advances, the administration of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) has demonstrated considerable effectiveness in decreasing mortality and morbidity, while also enhancing clinical outcomes among individuals with heart failure [126, 127].